Synthesis of antisense oligonucleotides: Replacement of 3H-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage reagent) with phenylacetyl disulfide (PADS) as efficient sulfurization reagent: From bench to bulk manufacture of active pharmaceutical ingredient

被引:47
作者
Cheruvallath, ZS [1 ]
Carty, RL [1 ]
Moore, MN [1 ]
Capaldi, DC [1 ]
Krotz, AH [1 ]
Wheeler, PD [1 ]
Turney, BJ [1 ]
Craig, SR [1 ]
Gaus, HJ [1 ]
Scozzari, AN [1 ]
Cole, DL [1 ]
Ravikumar, VT [1 ]
机构
[1] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1021/op990077b
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
It is demonstrated that phosphorothioate oligodeoxyribonucleotides can be synthesized on scales from 1 mu mol to 150 mmol using phenylacetyl disulfide (PADS) as an efficient and economical replacement for Beaucage reagent. A 0.2 M solution of PADS in a mixture of 3-picoline and acetonitrile (1:1 v/v) as solvent with 60-120 s contact time efficiently (>99.6%) sulfurizes phosphite triesters to phosphorothioate triester linkages. Phenylacetyl disulfide reagent is inexpensive and scaleable and is currently being used by us for the manufacture of antisense phosphorothioate oligodeoxyribonucleotide active pharmaceutical ingredients (API).
引用
收藏
页码:199 / 204
页数:6
相关论文
共 45 条
[1]   ADVANCES IN THE SYNTHESIS OF OLIGONUCLEOTIDES BY THE PHOSPHORAMIDITE APPROACH [J].
BEAUCAGE, SL ;
IYER, RP .
TETRAHEDRON, 1992, 48 (12) :2223-2311
[2]   THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES BY THE PHOSPHORAMIDITE APPROACH AND THEIR APPLICATIONS [J].
BEAUCAGE, SL ;
IYER, RP .
TETRAHEDRON, 1993, 49 (28) :6123-6194
[3]   Is it essential to use anhydrous acetonitrile in the manufacture of phosphorothioate oligonucleotides? [J].
Capaldi, DC ;
Scozzari, AN ;
Cole, DL ;
Ravikumar, VT .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (06) :485-487
[4]   Use of phenylacetyl disulfide (PADS) in the synthesis of oligodeoxyribonucleotide phosphorothioates [J].
Cheruvallath, ZS ;
Wheeler, PD ;
Cole, DL ;
Ravikumar, VT .
NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (03) :485-492
[5]  
COOK PD, 1991, ANTI-CANCER DRUG DES, V6, P585
[6]   Antisense therapeutics [J].
Crooke, ST .
BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, VOL. 15, 1998, 15 :121-157
[7]   An overview of progress in antisense therapeutics [J].
Crooke, ST .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (02) :115-122
[8]  
CROOKE ST, 1993, ANTISENSE RES A
[9]  
CROOKE ST, 1995, BURGERS MED CHEM DRU
[10]  
CROOKE ST, 1998, BASIC PRINCIPLES ANT